Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | MYC | P01106 | 1/20 | 0.51 |
| ▸ | MAX | P61244 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | EIF4E | P06730 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | CTSV | O60911 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6536346 | 0.91 | MYC (0.56) | ALDH1A1MAPTMYCMAXKMT2A | |
| SCHEMBL5696813 | 0.88 | ALDH1A1 (0.54) | ALDH1A1MAPTMYCMAXKMT2A | |
| SCHEMBL14099588 | 0.88 | ACHE (0.50) | ALDH1A1MAPTKMT2AACHEHSD17B10 | |
| SCHEMBL6641665 | 0.86 | MYC (0.66) | ALDH1A1MAPTMYCMAXKMT2A | |
| SCHEMBL3824237 | 0.85 | EIF4E (0.53) | ALDH1A1MAPTMYCMAXKMT2A | |
| SCHEMBL3824233 | 0.85 | EIF4E (0.53) | ALDH1A1MAPTMYCMAXKMT2A | |
| SCHEMBL6804809 | 0.84 | CYP46A1 (0.55) | ALDH1A1MAPTKMT2AACHEHSD17B10 | |
| SCHEMBL679262 | 0.84 | ALDH1A1 (0.62) | ALDH1A1MAPTMYCMAXKMT2A | |
| SCHEMBL6342762 | 0.84 | ALDH1A1 (0.62) | ALDH1A1MAPTMYCMAXKMT2A | |
| SCHEMBL6425009 | 0.83 | EIF4E (0.56) | ALDH1A1MAPTMYCMAXKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040157866-A1 | Amide compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157866-A1 | Amide compounds | APOB, NR1H2, NR1H3 | ALDH1A1 2901/4885MAPT 4047/4885MYC 4037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.